Cargando...
Helicobacter pylori therapy: a paradigm shift
Helicobacter pylori (H. Pylori) is a leading cause of gastroduodenal disease, including gastric cancer. H. pylori eradication therapies and their efficacy are summarized. A number of current treatment regimens will reliably yield >90% or 95% cure rates with susceptible strains. None has proven to...
Gardado en:
| Publicado en: | Expert Rev Anti Infect Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939773/ https://ncbi.nlm.nih.gov/pubmed/27077447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14787210.2016.1178065 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|